These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28823501)

  • 1. Quality of life metrics in arrhythmogenic right ventricular cardiomyopathy patients: The impact of age, shock and sex.
    Rhodes AC; Murray B; Tichnell C; James CA; Calkins H; Sears SF
    Int J Cardiol; 2017 Dec; 248():216-220. PubMed ID: 28823501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. General and disease-specific psychosocial adjustment in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy with implantable cardioverter defibrillators: a large cohort study.
    James CA; Tichnell C; Murray B; Daly A; Sears SF; Calkins H
    Circ Cardiovasc Genet; 2012 Feb; 5(1):18-24. PubMed ID: 22238189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of technology dependency on device acceptance and quality of life in persons with implantable cardioverter defibrillators.
    Udlis KA
    J Cardiovasc Nurs; 2013; 28(6):E65-73. PubMed ID: 23348222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival After Heart Transplantation in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    DePasquale EC; Cheng RK; Deng MC; Nsair A; McKenna WJ; Fonarow GC; Jacoby DL
    J Card Fail; 2017 Feb; 23(2):107-112. PubMed ID: 27154489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Presentation and Outcomes by Sex in Arrhythmogenic Right Ventricular Cardiomyopathy: Findings from the North American ARVC Registry.
    Choudhary N; Tompkins C; Polonsky B; McNitt S; Calkins H; Mark Estes NA; Krahn AD; Link MS; Marcus FI; Towbin JA; Zareba W
    J Cardiovasc Electrophysiol; 2016 May; 27(5):555-62. PubMed ID: 26840461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart transplantation in arrhythmogenic right ventricular cardiomyopathy - Experience from the Nordic ARVC Registry.
    Gilljam T; Haugaa KH; Jensen HK; Svensson A; Bundgaard H; Hansen J; Dellgren G; Gustafsson F; Eiskjær H; Andreassen AK; Sjögren J; Edvardsen T; Holst AG; Svendsen JH; Platonov PG
    Int J Cardiol; 2018 Jan; 250():201-206. PubMed ID: 29107359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Corrado D; Leoni L; Link MS; Della Bella P; Gaita F; Curnis A; Salerno JU; Igidbashian D; Raviele A; Disertori M; Zanotto G; Verlato R; Vergara G; Delise P; Turrini P; Basso C; Naccarella F; Maddalena F; Estes NA; Buja G; Thiene G
    Circulation; 2003 Dec; 108(25):3084-91. PubMed ID: 14638546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic expression is a prerequisite for malignant arrhythmic events and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy.
    Zorzi A; Rigato I; Pilichou K; Perazzolo Marra M; Migliore F; Mazzotti E; Gregori D; Thiene G; Daliento L; Iliceto S; Rampazzo A; Basso C; Bauce B; Corrado D
    Europace; 2016 Jul; 18(7):1086-94. PubMed ID: 26138720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ventricular ectopic QRS interval (VEQSI): Diagnosis of arrhythmogenic right ventricular cardiomyopathy in patients with incomplete disease expression.
    Bastiaenen R; Pantazis A; Gonna H; Chis-Ster I; Castelletti S; Batchvarov VN; Domenichini G; Coccolo F; Boriani G; McKenna WJ; Behr ER; Gallagher MM
    Heart Rhythm; 2016 Jul; 13(7):1504-12. PubMed ID: 27016477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Performance of Right Ventricular Implantable Cardioverter-Defibrillator Leads in Arrhythmogenic Right Ventricular Cardiomyopathy and Hypertrophic Cardiomyopathy.
    Sagawa Y; Nagata Y; Yamaguchi T; Mitsui K; Nagamine T; Yamaguchi J; Hijikata S; Watanabe K; Masuda R; Miyazaki R; Kaneko M; Miwa N; Sekigawa M; Hara N; Nozato T; Ashikaga T; Goya M; Sasano T; Hirao K
    Int Heart J; 2020 Jan; 61(1):39-45. PubMed ID: 31956141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrical Storm in ICD Recipients with Arrhythmogenic Right Ventricular Cardiomyopathy.
    Yin K; Ding L; Hua W; Zhang S
    Pacing Clin Electrophysiol; 2017 Jun; 40(6):683-692. PubMed ID: 28261825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
    Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Arrhythmic Burden but Low Mortality during Long-term Follow-up in Arrhythmogenic Right Ventricular Cardiomyopathy.
    Martin A; Crawford J; Skinner JR; Smith W;
    Heart Lung Circ; 2016 Mar; 25(3):275-81. PubMed ID: 26546095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease-specific quality of life-patient acceptance: racial and gender differences in patients with implantable cardioverter defibrillators.
    Wilson MH; Engelke MK; Sears SF; Swanson M; Neil JA
    J Cardiovasc Nurs; 2013; 28(3):285-93. PubMed ID: 22580627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable Cardioverter-Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications.
    Orgeron GM; James CA; Te Riele A; Tichnell C; Murray B; Bhonsale A; Kamel IR; Zimmerman SL; Judge DP; Crosson J; Tandri H; Calkins H
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28588093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Registry Evaluating Functional Outcomes of Resynchronization Management (REFORM): quality of life and psychological functioning in patients receiving cardiac resynchronization therapy.
    Ford J; Sears S; Ramza B; Reynolds DW; Nguyen P; Fedewa M; House J; Kennedy P; Thompson R; Murray C
    J Cardiovasc Electrophysiol; 2014 Jan; 25(1):43-51. PubMed ID: 24102945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac phenotype and long-term prognosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia patients with late presentation.
    Bhonsale A; Te Riele ASJM; Sawant AC; Groeneweg JA; James CA; Murray B; Tichnell C; Mast TP; van der Pols MJ; Cramer MJM; Dooijes D; van der Heijden JF; Tandri H; van Tintelen JP; Judge DP; Hauer RNW; Calkins H
    Heart Rhythm; 2017 Jun; 14(6):883-891. PubMed ID: 28215569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia (ARVC/D): Review of 16 Pediatric Cases and a Proposal of Modified Pediatric Criteria.
    Deshpande SR; Herman HK; Quigley PC; Shinnick JK; Cundiff CA; Caltharp S; Shehata BM
    Pediatr Cardiol; 2016 Apr; 37(4):646-55. PubMed ID: 26743400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arrhythmogenic Right Ventricular Cardiomyopathy: Risk Stratification and Indications for Defibrillator Therapy.
    Zorzi A; Rigato I; Bauce B; Pilichou K; Basso C; Thiene G; Iliceto S; Corrado D
    Curr Cardiol Rep; 2016 Jun; 18(6):57. PubMed ID: 27147509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychological wellbeing and posttraumatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease.
    Ingles J; Sarina T; Kasparian N; Semsarian C
    Int J Cardiol; 2013 Oct; 168(4):3779-84. PubMed ID: 23835269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.